Navya Joseph
Neurology · Lincoln, NENPI 1306366364
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 39 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 13.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $437 and has fallen 96.5% since, to $15 in 2023. That places this record below the midpoint for neurology clinicians in NE, where the typical reported total is $1,038.
Across 39 payments — averaging $19.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$100
- Johnson & Johnson$91
- Upsher-smith Laboratories LLC$63
- Neurocrine Biosciences, Inc.$59
- UCB, Inc.$58
- Biohaven Pharmaceutical Holding Company Ltd.$40
- plus $358 from 17 others
What the payments were for
- Food & beverage$768100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 4 | $100 |
| Johnson & Johnson | 3 | $91 |
| Upsher-smith Laboratories LLC | 3 | $63 |
| Neurocrine Biosciences, Inc. | 3 | $59 |
| UCB, Inc. | 3 | $58 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $40 |
| Novartis | 2 | $33 |
| SK Life Science, Inc. | 2 | $32 |
| Acadia Pharmaceuticals Inc | 2 | $30 |
| Eisai Inc. | 2 | $26 |
| MDD US Operations, LLC | 1 | $25 |
| Lundbeck LLC | 1 | $24 |
| Amgen | 1 | $20 |
| Genentech USA, Inc. | 1 | $18 |
| Kyowa Kirin, Inc. | 1 | $18 |
| AstraZeneca | 1 | $18 |
| Amneal Pharmaceuticals LLC | 1 | $17 |
| Biogen | 1 | $17 |
| Medtronic | 1 | $17 |
| Livanova USA, Inc. | 1 | $17 |
| Biohaven Pharmaceuticals, Inc. | 1 | $16 |
| Avanir Pharmaceuticals, Inc. | 1 | $15 |
| GRT US Holding, Inc. | 1 | $14 |
How this compares
$768 in reported general payments places this provider in the 45th percentile of 105 neurology providers in Nebraska.
Other neurology in Lincoln
- Gary PatteeLincoln$132K
- James BobenhouseLincoln$14K
- Ana DelgadoLincoln$11K
- Brian BoesLincoln$8K
- Michael VavraLincoln$7K
- Matthew PurbaughLincoln$7K
- Matthew KnissLincoln$5K
- Daniel Crespo ArtunduagaLincoln$5K
- Vekash RajaLincoln$3K
- Erin DennisLincoln$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.